ENDOMETRIAL
Clinical trials for ENDOMETRIAL explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL trials appear
Sign up with your email to follow new studies for ENDOMETRIAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail targets Hard-to-Treat endometrial cancer
Disease control Recruiting nowThis early-phase study tests a combination of three drugs (avutometinib, defactinib, and everolimus) in people with recurrent endometrial cancer that has specific genetic changes in the RAS pathway. The main goal is to find a safe dose and understand side effects. About 31 partic…
Matched conditions: ENDOMETRIAL
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Promising drug targets HER2 cancers in new trial
Disease control Recruiting nowThis phase 2 trial tests zanidatamab, a drug that targets cancer cells with a HER2 gene alteration, in 105 adults with advanced lung, endometrial, colorectal, head & neck, or sarcoma cancers. Participants receive the drug every 3 weeks, and doctors monitor tumor shrinkage and sid…
Matched conditions: ENDOMETRIAL
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC